Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza
The Journal of Infectious Diseases · 17.10.2025 · 232 (Supplement_3) · S347-S358
DOI: 10.1093/infdis/jiaf216 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 17.10.2025. Verfasst von John H Beigel und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Allergy and Infectious Diseases, Rockville, Maryland. Hauptthemen laut MEDLINE: Influenza, Human, Antibodies, Monoclonal, Antibodies, Viral. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
While at least 8 monoclonal and 3 polyclonal antibody products have been tested in clinical trials for the treatment of influenza, no products have been licensed, and most have stopped clinical development. The COVID-19 pandemic demonstrated that these approaches, especially monoclonal antibodies, may have unique potential in certain stages of disease and populations, especially in preventing severe disease in a population without preexisting immunity or in those with a limited capacity to mount an effective humoral immune response. This review summarizes past and ongoing efforts in using monoclonal and polyclonal antibodies for the treatment and prevention of influenza, focusing on products that have entered clinical trials and drawing lessons from COVID-19 to direct future efforts on these strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Institute of Allergy and Infectious Diseases, Rockville, Maryland.
- Visterra, Inc, Waltham, Massachusetts.
ORCID-Profile: John H Beigel
Förderung
- National Institute of Allergy and Infectious Diseases
- NIH HHS
- National Institutes of Health
Zitieren
APA
Beigel, J. H., & Oldach, D. (2025). Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza. The Journal of Infectious Diseases, 232(Supplement_3), S347-S358. https://doi.org/10.1093/infdis/jiaf216
Vancouver
Beigel JH, Oldach D. Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza. The Journal of Infectious Diseases. 2025;232(Supplement_3):S347-S358. doi:10.1093/infdis/jiaf216
BibTeX
@article{Beigel2025,
author = {Beigel, John H and Oldach, David},
title = {Polyclonal and Monoclonal Antibodies for the Treatment and Prevention of Influenza},
journal = {The Journal of Infectious Diseases},
year = {2025},
volume = {232},
number = {Supplement_3},
pages = {S347--S358},
doi = {10.1093/infdis/jiaf216}
}
EUVIMED